Structure of the activating natural killer cell receptor NKp30 bound to its ligand B7-H6 reveals basis for tumor cell recognition in humans
Li, Y., Wang, Q., Mariuzza, R.A.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Ig-like domain-containing protein DKFZp686O24166/DKFZp686I21167 | 248 | Homo sapiens | Mutation(s): 0  | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q68D85 (Homo sapiens) Explore Q68D85  Go to UniProtKB:  Q68D85 | |||||
PHAROS:  Q68D85 GTEx:  ENSG00000188211  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q68D85 | ||||
Glycosylation | |||||
Glycosylation Sites: 3 | Go to GlyGen: Q68D85-1 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Natural cytotoxicity triggering receptor 3 | 117 | Homo sapiens | Mutation(s): 0  Gene Names: NCR3, 1C7, LY117 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for O14931 (Homo sapiens) Explore O14931  Go to UniProtKB:  O14931 | |||||
PHAROS:  O14931 GTEx:  ENSG00000204475  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | O14931 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
NAG Query on NAG | D [auth A], E [auth A] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 50.874 | α = 90 |
b = 74.868 | β = 90 |
c = 125.534 | γ = 90 |
Software Name | Purpose |
---|---|
CNS | refinement |
PDB_EXTRACT | data extraction |
ADSC | data collection |
DENZO | data reduction |
SCALEPACK | data scaling |
HKL-2000 | data scaling |
PHASES | phasing |